Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger B, Piñón Hofbauer J, Wally V, Arzt C, Hainzl S, Kocher T, Murauer EM, Bauer JW, Reichelt J, Koller U. Liemberger B, et al. Among authors: bauer jw. Int J Mol Sci. 2018 Mar 7;19(3):762. doi: 10.3390/ijms19030762. Int J Mol Sci. 2018. PMID: 29518954 Free PMC article.
Improved Double-Nicking Strategies for COL7A1-Editing by Homologous Recombination.
Kocher T, Wagner RN, Klausegger A, Guttmann-Gruber C, Hainzl S, Bauer JW, Reichelt J, Koller U. Kocher T, et al. Among authors: bauer jw. Mol Ther Nucleic Acids. 2019 Dec 6;18:496-507. doi: 10.1016/j.omtn.2019.09.011. Epub 2019 Sep 20. Mol Ther Nucleic Acids. 2019. PMID: 31670199 Free PMC article.
Epigenetic and metabolic regulation of epidermal homeostasis.
Wagner RN, Piñón Hofbauer J, Wally V, Kofler B, Schmuth M, De Rosa L, De Luca M, Bauer JW. Wagner RN, et al. Among authors: bauer jw. Exp Dermatol. 2021 Aug;30(8):1009-1022. doi: 10.1111/exd.14305. Epub 2021 Mar 10. Exp Dermatol. 2021. PMID: 33600038 Free PMC article. Review.
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
Ablinger M, Lettner T, Friedl N, Potocki H, Palmetzhofer T, Koller U, Illmer J, Liemberger B, Hainzl S, Klausegger A, Reisenberger M, Lambert J, Van Gele M, Desmet E, Van Maelsaeke E, Wimmer M, Zauner R, Bauer JW, Wally V. Ablinger M, et al. Among authors: bauer jw. Int J Mol Sci. 2021 Mar 24;22(7):3326. doi: 10.3390/ijms22073326. Int J Mol Sci. 2021. PMID: 33805154 Free PMC article.
Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa.
Rathner A, Rathner P, Friedrich A, Wießner M, Kitzler CM, Schernthaner J, Karl T, Krauß J, Lottspeich F, Mewes W, Hintner H, Bauer JW, Breitenbach M, Müller N, Breitenbach-Koller H, von Hagen J. Rathner A, et al. Among authors: bauer jw. Skin Pharmacol Physiol. 2021;34(4):167-182. doi: 10.1159/000513260. Epub 2021 Apr 6. Skin Pharmacol Physiol. 2021. PMID: 33823521
Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa.
Welponer T, Prodinger C, Pinon-Hofbauer J, Hintersteininger A, Breitenbach-Koller H, Bauer JW, Laimer M. Welponer T, et al. Among authors: bauer jw. Dermatol Ther (Heidelb). 2021 Aug;11(4):1175-1197. doi: 10.1007/s13555-021-00561-5. Epub 2021 Jun 10. Dermatol Ther (Heidelb). 2021. PMID: 34110606 Free PMC article. Review.
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.
Woess K, Sun Y, Morio H, Stierschneider A, Kaufmann A, Hainzl S, Trattner L, Kocher T, Tockner B, Leb-Reichl V, Steiner M, Brachtl G, South AP, Bauer JW, Reichelt J, Furihata T, Wally V, Koller U, Piñón Hofbauer J, Guttmann-Gruber C. Woess K, et al. Among authors: bauer jw. Int J Mol Sci. 2022 Jan 5;23(1):575. doi: 10.3390/ijms23010575. Int J Mol Sci. 2022. PMID: 35008999 Free PMC article.
226 results